Bioequivalence Comparison of Pediatric Dasatinib Formulations and Elucidation of Absorption Mechanisms Through Integrated PBPK Modeling
Authors:
- 1 January 2019
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 108 (1) , 741-749
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Development and applications of a physiologically-based model of paediatric oral drug absorptionEuropean Journal of Pharmaceutical Sciences, 2018
- In vitro dissolution methodology, mini-Gastrointestinal Simulator (mGIS), predicts better in vivo dissolution of a weak base drug, dasatinibEuropean Journal of Pharmaceutical Sciences, 2015
- Identification of the Human Enzymes Involved in the Oxidative Metabolism of Dasatinib: An Effective Approach for Determining Metabolite Formation KineticsDrug Metabolism and Disposition, 2008
- Biotransformation of [14C]Dasatinib: In Vitro Studies in Rat, Monkey, and Human and Disposition after Administration to Rats and MonkeysDrug Metabolism and Disposition, 2008
- Dasatinib in Imatinib-Resistant Philadelphia Chromosome–Positive LeukemiasNew England Journal of Medicine, 2006
- Predicting the impact of physiological and biochemical processes on oral drug bioavailabilityAdvanced Drug Delivery Reviews, 2001
- An Integrated Model for Determining Causes of Poor Oral Drug AbsorptionPharmaceutical Research, 1999
- A compartmental absorption and transit model for estimating oral drug absorptionInternational Journal of Pharmaceutics, 1999
- Transport approaches to the biopharmaceutical design of oral drug delivery systems: prediction of intestinal absorptionAdvanced Drug Delivery Reviews, 1996
- Effect of size and density on canine gastric emptying of nondigestible solidsGastroenterology, 1985